Analysts are on the Bearish side about Indivior PLC (LON:INDV) this week.

October 13, 2017 - By Maria Brooks

 Analysts are on the Bearish side about Indivior PLC (LON:INDV) this week.

Indivior PLC (LON:INDV) Ratings Coverage

Among 8 analysts covering Indivior Plc (LON:INDV), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Indivior Plc had 98 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Deutsche Bank on Monday, June 6 with “Buy”. Citigroup maintained Indivior PLC (LON:INDV) rating on Wednesday, May 4. Citigroup has “Buy” rating and GBX 230 target. On Monday, August 1 the stock rating was maintained by Deutsche Bank with “Buy”. Numis Securities maintained Indivior PLC (LON:INDV) rating on Monday, September 26. Numis Securities has “Buy” rating and GBX 370 target. The stock of Indivior PLC (LON:INDV) has “Buy” rating given on Tuesday, July 26 by Jefferies. The stock of Indivior PLC (LON:INDV) earned “Buy” rating by Deutsche Bank on Thursday, August 11. The firm has “Buy” rating by Deutsche Bank given on Monday, November 30. Stifel Nicolaus maintained Indivior PLC (LON:INDV) rating on Wednesday, August 17. Stifel Nicolaus has “Buy” rating and GBX 350 target. The firm has “Buy” rating given on Friday, July 29 by Stifel Nicolaus. The firm has “Buy” rating given on Wednesday, January 13 by Jefferies. Below is a list of Indivior PLC (LON:INDV) latest ratings and price target changes.

08/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 540.00 New Target: GBX 358.00 Maintain
05/09/2017 Broker: Citigroup Rating: Neutral Old Target: GBX 280.00 New Target: GBX 280.00 Maintain
01/09/2017 Broker: Numis Securities Rating: Buy New Target: GBX 470.00 Maintain
11/08/2017 Broker: Jefferies Rating: Buy Old Target: GBX 490.00 New Target: GBX 540.00 Maintain
03/08/2017 Broker: RBC Capital Markets Rating: Outperform New Target: GBX 470.00 Maintain
28/07/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: GBX 390.00 New Target: GBX 470.00 Upgrade
27/07/2017 Broker: Numis Securities Rating: Buy New Target: GBX 490.00 Maintain
11/07/2017 Broker: Numis Securities Rating: Buy Old Target: GBX 490.00 New Target: GBX 490.00 Maintain
07/06/2017 Broker: Jefferies Rating: Buy Old Target: GBX 490.00 New Target: GBX 490.00 Maintain
31/05/2017 Broker: Numis Securities Rating: Buy New Target: GBX 490.00 Maintain

The stock decreased 1.00% or GBX 3.42 on October 13, reaching GBX 337.68. About 1.20M shares traded. Indivior PLC (LON:INDV) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Indivior PLC is a specialty pharmaceutical company. The company has market cap of 2.43 billion GBP. The Firm is engaged in the development, manufacture and sale of buprenorphine prescription drugs for the treatment of opioid dependence (the Indivior Business). It has a 47.73 P/E ratio. The Company’s treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia.

More notable recent Indivior PLC (LON:INDV) news were published by: Prnewswire.com which released: “Indivior PLC Announces FDA Acceptance with Priority Review Designation of RBP …” on July 31, 2017, also Prnewswire.com with their article: “DURECT and Indivior PLC Sign a $17.5 Million Patent Purchase Agreement” published on October 02, 2017, Prnewswire.com published: “Indivior PLC Presents Results from the Phase 3 Pivotal Study of RBP-6000 …” on June 21, 2017. More interesting news about Indivior PLC (LON:INDV) were released by: Seekingalpha.com and their article: “Indivior Treads Forward In Opioid Addiction Market” published on June 06, 2017 as well as Seekingalpha.com‘s news article titled: “Indivior Could Fall Further Once Generic Suboxone Arrives” with publication date: September 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.